Date: 2022-10-27Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision of the EEA Joint Committee No 118/2019 of 8 May 2019 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2022/2016]
**Policy Summary:**
EEA Joint Committee Decision No. 118/2019, enacted on May 8, 2019, amends Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement. This decision incorporates Commission Implementing Decision (EU) 2018/1985, which disapproves Willaertia magna C2C Maky as an active substance for use in biocidal products of product-type 11, into the EEA Agreement. The amendment adds point "12zzzzzv" to Chapter XV of Annex II, referencing "32018 D 1985: Commission Implementing Decision (EU) 2018/1985." The decision stipulates that the Icelandic and Norwegian language versions of Implementing Decision (EU) 2018/1985 will be published in the EEA Supplement to the Official Journal of the European Union and are considered authentic. This decision entered into force on June 1, 2019, following completion of notifications under Article 103(1) of the EEA Agreement. The decision was published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Key Entities Referenced
EEA Joint Committee: The decision-making body responsible for amending the EEA Agreement.
EEA Agreement: The Agreement on the European Economic Area, which extends the EU's single market to Iceland, Liechtenstein and Norway.
Annex II to the EEA Agreement: A section of the EEA Agreement concerning technical regulations, standards, testing, and certification.
Commission Implementing Decision EU 2018/1985: A decision by the European Commission regarding the non-approval of Willaertia magna c2c maky as an active substance for use in biocidal products.
Willaertia magna c2c maky: An active substance considered for use in biocidal products, but not approved by Commission Implementing Decision EU 2018/1985.
Brussels: The city where the decision of the EEA Joint Committee was made.
Iceland: One of the countries to which the EEA agreement extends
Norway: One of the countries to which the EEA agreement extends
L 279/16 EN Official Journal of the European Union 27.10.2022
DECISION OF THE EEA JOINT COMMITTEE No 118/2019
of 8 May 2019
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
[2022/2016]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98
thereof,
Whereas:
(1) Commission Implementing Decision (EU) 2018/1985 of 13 December 2018 not approving Willaertia magna c2c
maky as an active substance for use in biocidal products of product-type 11(1)is to be incorporated into the EEA
Agreement.
(2) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
The following point is inserted after point 12zzzzzu (Commission Implementing Decision (EU) 2018/1305) of Chapter XV
of Annex II to the EEA Agreement:
‘12zzzzzv. 32018 D 1985: Commission Implementing Decision (EU) 2018/1985 of 13 December 2018not approving
Willaertia magna c2c maky as an active substance for use in biocidal products of product-type 11 (OJ L 317,
14.12.2018, p. 27).’
Article 2
The text of Implementing Decision (EU) 2018/1985 in the Icelandic and Norwegian languages, to be published in the EEA
Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 1 June 2019, provided that all the notifications under Article 103(1) of the EEA
Agreement have been made*.
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European
Union.
Done at Brussels, 8 May 2019.
For the EEA Joint Committee
The President
Claude MAERTEN
(1) OJ L 317, 14.12.2018, p. 27.
(*) No constitutional requirements indicated.